Updates in Lung Cancer Management (PRO 04)
This activity covers 4 main topics: 1) The current standard of care for management of stage III non-small cell lung cancer, 2) Palliation of common issues such as hemoptysis, airway obstruction, and chest pain. 3) Management of patients ineligible for chemotherapy due to poor performance status/comorbidities 4) Comparison and contrast of volume definition in small cell lung cancer, prior to chemotherapy initiation, during chemotherapy (Cycle 2 or later, and as consolidation after initial course of chemotherapy for extensive stage is complete.)
This activity is designed to meet the interests of radiation oncologists.
Upon completion of this live activity, participants should be able to do the following:
- Contour planning volumes to the current standard of care
- Select appropriate dose/fractionation schedule for common palliative scenarios.
Christopher Hays Pope, MD, is employed by CARTI. Dr. Pope is a Partner/Vice President of Radiation Oncology Associates, P.A.
Saumil Gandhi, MD, PhD, is employed by The University of Texas MD Anderson Cancer Center. Dr. Gandhi receives research funding from Nanobiotix, BMS, and the BMS Foundation.
Uzoma Kevin Iheagwara, MD, PhD, is employed by University of Pittsburgh Medical Center/UPMC Hillman Cancer Center.
Sara J. Zakem, MD, BS, is employed by University of Washington/Fred Hutch Cancer Center.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.25 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.